Last10K.com

Genetic Technologies Ltd (GENE) SEC Filing 20-F Annual report for the fiscal year ending Saturday, June 30, 2018

Genetic Technologies Ltd

CIK: 1166272 Ticker: GENE

View differences made from one year to another to evaluate Genetic Technologies Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Genetic Technologies Ltd.

Continue

Assess how Genetic Technologies Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Genetic Technologies Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Comprehensive Income/ (Loss)
Accumulated Losses
Accumulated Losses (Details)
Accumulated Losses (Tables)
Auditors' Remuneration
Auditors' Remuneration (Details)
Auditors' Remuneration (Tables)
Cash And Cash Equivalents
Cash And Cash Equivalents (Details)
Cash And Cash Equivalents (Tables)
Commitments And Contingencies
Commitments And Contingencies (Tables)
Commitments And Contingencies - Operating Lease Expenditure Commitments (Details)
Commitments And Contingencies - Operating Lease Minimum Payments (Details)
Contributed Equity
Contributed Equity (Details)
Contributed Equity (Tables)
Corporate Information
Cost Of Sales
Cost Of Sales (Details)
Cost Of Sales (Tables)
Critical Accounting Estimates And Judgements
Expenses
Expenses (Details)
Expenses (Tables)
Financial Risk Management
Financial Risk Management (Tables)
Financial Risk Management - Credit Risk (Details)
Financial Risk Management - Financial Instruments (Details)
Financial Risk Management - Foreign Currency Risk (Details)
Financial Risk Management - Interest Rate Risk (Details)
Financial Risk Management - Liquidity Risk (Details)
Foreign Exchange Gain Reclassified On Liquidation Of Subsidiary
Foreign Exchange Gain Reclassified On Liquidation Of Subsidiary (Details)
Foreign Exchange Gain Reclassified On Liquidation Of Subsidiary (Tables)
Income Tax
Income Tax (Tables)
Income Tax - Net Deferred Tax Assets (Details)
Income Tax - Reconciliation Of Income Tax Expense To Prima Facie Tax Payable (Details)
Income Tax - Tax Losses (Details)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Tables)
Intangible Assets - Impairment (Details)
Intangible Assets - Reconciliation (Details)
Loss Per Share
Loss Per Share (Details)
Loss Per Share (Tables)
Non Operating Income And Expenditure
Non Operating Income And Expenditure (Details)
Non Operating Income And Expenditure (Tables)
Options
Options (Tables)
Options - Movements In Options Granted (Details)
Options - Options Outstanding (Details)
Options - Options Outstanding By Asx Code (Details)
Other Revenue
Other Revenue (Details)
Other Revenue (Tables)
Prepayments And Other Assets (Current)
Prepayments And Other Assets (Current) (Details)
Prepayments And Other Assets (Current) (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Reconciliation (Details)
Provisions (Current And Non-Current)
Provisions (Current And Non-Current) (Details)
Provisions (Current And Non-Current) (Tables)
Provisions (Current And Non-Current) - Reconciliation Of Provision (Details)
Related Party Disclosures
Related Party Disclosures (Details)
Related Party Disclosures (Tables)
Reserves
Reserves (Details)
Reserves (Tables)
Segment Information
Segment Information (Details)
Segment Information (Tables)
Segment Information - Additional Segment Disclosures (Details)
Segment Information - Geographic Information (Details)
Share Based Payments
Share Based Payments (Details)
Share Based Payments (Tables)
Share Based Payments - Expenses Arising From Share-Based Payment Transactions (Details)
Subsequent Events
Subsequent Events (Details)
Subsidiaries
Subsidiaries (Details)
Subsidiaries (Tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies - Intangible Assets (Details)
Summary Of Significant Accounting Policies - Property, Plant And Equipment (Details)
Trade And Other Payables (Current)
Trade And Other Payables (Current) (Details)
Trade And Other Payables (Current) (Tables)
Trade And Other Receivables (Current)
Trade And Other Receivables (Current) (Details)
Trade And Other Receivables (Current) (Tables)
Ticker: GENE
CIK: 1166272
Form Type: 20-F Annual Report
Accession Number: 0001104659-18-064930
Submitted to the SEC: Wed Oct 31 2018 8:57:49 AM EST
Accepted by the SEC: Wed Oct 31 2018
Period: Saturday, June 30, 2018
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/gene/0001104659-18-064930.htm